TFG today announces in furtherance of its share repurchase
program announced on November 30, 2007, that for the period of January 3,
2011 through January 7, 2011 TFG purchased 71,024 of its shares for an 
average price of U.S. $5.94per share.

    About Tetragon:

    Tetragon Financial Group Limited (TFG) is a Guernsey
closed-ended investment company traded on Euronext Amsterdam by NYSE
Euronextunder the ticker symbol "TFG."

    Tetragon Financial Group Limited (TFG) is a Guernsey
closed-ended investment company traded on Euronext Amsterdam by NYSE Euronext
under the ticker symbol "TFG" that currently invests primarily through
long-term funding vehicles such as collateralized loan obligations in
selected securitized asset classes and aims to provide stable returns to
investors across various interest rate and credit cycles.

    This release does not contain or constitute an offer to sell
or a solicitation of an offer to purchase securities in the United States or
any other jurisdiction. The securities of TFG have not been and will not be
registered under the US Securities Act of 1933 (the "Securities Act"), as
amended, and may not be offered or sold in the United States or to US persons
unless they are registered under applicable law or exempt from registration.
TFG does not intend to register any portion of its securities in the United
States or to conduct a public offer of securities in the United States. In
addition, TFG has not been and will not be registered under the US Investment
Company Act of 1940, and investors will not be entitled to the benefits of
such Act. TFG is registered in the public register of the Netherlands
Authority for the Financial Markets under Section 1:107 of the Financial
Markets Supervision Act as a collective investment scheme from a designated
country.
    
    For further information, please contact:
    TFG:                                     Press Inquiries:
    David Wishnow/Yuko Thomas                CitigateDeweRogerson
    Investor Relations                       Michael Berkeley/Justin
    ir@tetragoninv.com                       Griffiths/Clare Simonds
                                             + 44(0)20-7638-9571
                                             tetragon@citigatedr.co.uk
The content and accuracy of news releases published on this site and/or distributed by PR Newswire or its partners are the sole responsibility of the originating company or organisation. Whilst every effort is made to ensure the accuracy of our services, such releases are not actively monitored or reviewed by PR Newswire or its partners and under no circumstances shall PR Newswire or its partners be liable for any loss or damage resulting from the use of such information. All information should be checked prior to publication.